418.05
-14.31
(-3.31%)
At close: January 10 at 4:00:02 PM EST
417.01
-1.04
(-0.25%)
After hours: January 10 at 7:29:46 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 7 | 13 |
| Avg. Estimate | 2.4 | 3.03 | 10.73 | 11.89 |
| Low Estimate | 2.35 | 2.92 | 10.42 | 11.31 |
| High Estimate | 2.47 | 3.1 | 11.04 | 12.25 |
| Year Ago EPS | 2.32 | 2.81 | 10.06 | 10.73 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 11 | 12 |
| Avg. Estimate | 936.68M | 1.02B | 3.88B | 4.16B |
| Low Estimate | 930.17M | 1.02B | 3.87B | 4.1B |
| High Estimate | 947.2M | 1.04B | 3.91B | 4.2B |
| Year Ago Sales | 901.6M | 964.1M | 3.66B | 3.88B |
| Sales Growth (year/est) | 3.89% | 6.29% | 6.07% | 7.18% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 2.12 | 2.68 | 2.87 | 2.69 |
| EPS Actual | 2.32 | 2.81 | 3.02 | 2.8 |
| Difference | 0.2 | 0.13 | 0.15 | 0.11 |
| Surprise % | 9.39% | 4.79% | 5.20% | 4.26% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.4 | 3.03 | 10.73 | 11.89 |
| 7 Days Ago | 2.4 | 3.03 | 10.73 | 11.89 |
| 30 Days Ago | 2.4 | 3.04 | 10.73 | 11.91 |
| 60 Days Ago | 2.38 | 3.02 | 10.78 | 11.91 |
| 90 Days Ago | 2.52 | 3.08 | 10.83 | 12.22 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 3 | -- |
| Up Last 30 Days | -- | -- | 3 | -- |
| Down Last 7 Days | 8 | 1 | -- | 1 |
| Down Last 30 Days | 8 | 1 | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IDXX | 3.38% | 7.81% | 6.66% | 10.81% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 12/2/2024 |
| Reiterates | Piper Sandler: Neutral to Neutral | 11/4/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/4/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/11/2024 |
| Maintains | Stifel: Hold to Hold | 10/10/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 8/14/2024 |
Related Tickers
MEDP Medpace Holdings, Inc.
350.87
-1.05%
WAT Waters Corporation
380.35
+1.64%
MTD Mettler-Toledo International Inc.
1,210.99
-2.85%
DHR Danaher Corporation
235.07
-1.27%
TMO Thermo Fisher Scientific Inc.
542.31
-0.48%
LH Labcorp Holdings Inc.
232.00
-0.99%
IQV IQVIA Holdings Inc.
203.27
-0.51%
ICLR ICON Public Limited Company
218.22
-0.51%
DGX Quest Diagnostics Incorporated
151.79
-1.45%
A Agilent Technologies, Inc.
137.47
+0.34%